- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/26 - Interleukin-2
Patent holdings for IPC class C12N 15/26
Total number of patents in this class: 102
10-year publication summary
|
3
|
2
|
1
|
10
|
15
|
20
|
6
|
7
|
10
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Roche Glycart AG | 140 |
5 |
| Innovent Biologics (Suzhou) Co., Ltd. | 234 |
4 |
| Shanghai Shengdi Pharmaceutical Co., Ltd | 116 |
4 |
| Leto Laboratories Co., Ltd | 18 |
4 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
3 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 615 |
3 |
| Medikine, Inc. | 41 |
3 |
| Synthorx, Inc. | 76 |
3 |
| Shanghai GP Biotech Co. Ltd. | 4 |
3 |
| Amgen Inc. | 3961 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6284 |
2 |
| Medicenna Therapeutics Inc. | 37 |
2 |
| Nektar Therapeutics | 441 |
2 |
| ProLynx LLC | 50 |
2 |
| Soonchunhyang University Industry Academy Cooperation Foundation | 156 |
2 |
| Tilt Biotherapeutics Oy | 26 |
2 |
| Wuxi Biologics (Shanghai) Co. Ltd. | 142 |
2 |
| WuXi Biologics Ireland Limited | 246 |
2 |
| Amcyte Pharma, Inc. | 8 |
2 |
| Innovent Biologics (Singapore) Pte. Ltd. | 5 |
2 |
| Other owners | 48 |